Bicycle Therapeutics PLC (BCYC) stock
BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.20+0.02 (+0.63%)
Close on Nov 17, 2026Market cap $224.30MP/E –Yield 0.00%
Bicycle Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Bicycle Therapeutics's price to book ratio was 0.5× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.5× to 9.1×, with a median of 1.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.5× | −0.3 |
| 2025 | Dec 31, 2025 | 0.8× | −0.4 |
| 2024 | Dec 31, 2024 | 1.2× | −0.7 |
| 2023 | Dec 29, 2023 | 1.8× | −1.2 |
| 2022 | Dec 30, 2022 | 3.0× | −6.1 |
| 2021 | Dec 31, 2021 | 9.1× | +5.7 |
| 2020 | Dec 31, 2020 | 3.4× | +1.7 |
| 2019 | Dec 31, 2019 | 1.8× | – |
See a number that looks wrong?